PRMT5 and breast cancer: Regarding the breast, very few studies have addressed the potential pro-tumorigenic role of PRMT5, despite high PRMT5 expression being associated with breast cancer progression, aggressive disease, and poor prognosis (Chen et al., 2017, Powers et al., 2011, Yang et al., 2015).